NUCB2 and gastric cancer: The serum levels of NUCB2/nesfatin‐1 were positively correlated to the relative protein expression of NUCB2/nesfatin‐1 (IOD) in GS tissues in patients with GC (r = 0.646, p < 0.001; Figure 1D).